Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia

The purpose of this study is to determine whether recombinant human thrombopoietin(rhTPO) can rapidly increase the platelets counts, shorten the time of the platelet returned to normal, reduce

  • 0 views
  • 05 Mar, 2021
  • 1 location
The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy

Randomized, open-label study to compare the efficacy and safety of prednisone plus recombinant human thrombopoietin (rhTPO) compared to prednisone monotherapy for the treatment of immune

  • 0 views
  • 06 May, 2022
  • 1 location
Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

This is a prospective, multicenter, randomized, open-label study to investigate the efficacy and safety of eltrombopag plus recombinant human thrombopoietin (rhTPO) versus eltrombopag as

platelet count
corticosteroids
covid-19
thrombocytopenia
recombinant human thrombopoietin
  • 0 views
  • 25 Jan, 2021
  • 1 location
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study

was designed to assess the efficacy and safety of two hematologic growth factors, recombinant human thrombopoietin (rhTPO) and granulocyte colonystimulating factor (G-CSF), in combination with

decitabine
cytarabine
filgrastim
granulocyte colony stimulating factor
  • 0 views
  • 17 Mar, 2022
  • 1 location
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

was designed to assess the efficacy and safety of two hematologic growth factors, recombinant human thrombopoietin (rhTPO) and granulocyte colonystimulating factor (G-CSF), in combination with

decitabine
granulocyte colony stimulating factor
filgrastim
cytarabine
  • 0 views
  • 04 Jun, 2022
  • 1 location
Eltrombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy and safety of eltrombopag to treat chemotherapy-induced thrombocytopenia in solid tumors

  • 0 views
  • 25 Mar, 2022
  • 1 location
Herombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy and safety of Herombopag to treat chemotherapy-induced thrombocytopenia in Solid Tumors

  • 0 views
  • 22 Mar, 2022
  • 1 location
Avatrombopag for Chemotherapy-induced Thrombocytopenia

To evaluate the efficacy and safety of Avatrombopag to treat chemotherapy-induced thrombocytopenia in solid tumors

  • 0 views
  • 23 Mar, 2022
  • 1 location
D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

With the aging of society, the incidence of elderly leukemia in China has been increasing year by year. The elderly patients with Acute Leukemia have poor basal state, and there are many important organ diseases such as heart, liver and kidney. The incidence of infection and hemorrhage is high in …

colony stimulating factor
decitabine
filgrastim
cytarabine
acute leukemia
  • 0 views
  • 18 Feb, 2022
  • 1 location